|Haller||Haas, A. P., Eliason, E., Mays, V. M., Mathy, R. M., Cochran, S. D., D'Augelli, A. R., Silverman, M. M., Fisher, P. W., Hughes, T., Rosario, M., Russell, S. T., Malley. E., Reed, J., Litts, D. A., Haller, E., Sell, R. L., Remafedi, G., Bradford, J., Beautrais, A. L., Brown, G. K., Diamond, G. M., Friedman, M. S., Garofalo, R., Turner, M. S., Hollibaugh, A., & Clayton, P. J. (2011) Suicide and suicide risk in lesbian, gay, bisexual, and transgender populations: Review and recommendations. Journal of Homosexuality, 58, 10-51.
Ng, R. C., Hirata, C. K., Yeung, W., Haller, E., & Finley, P. R. (2010) Pharmacologic treatment for postpartum depression: A systematic review. Pharmacotherapy, 30(9), 928-41.
Mackin, R. S. , Delucchi, K., Bennett, B., & Arean, P. A. (2011) The effect of cognitive impairment on mental healthcare costs for individuals with severe psychiatric illness. American Journal of Geriatric Psychiatry, 2(19), 176-184.
Mackin, R. S. , Mathews, C., Delucchi, K., & Arean, P. A. (2011) Cognitive functioning in older adults with depression and severe compulsive hoarding behaviors. International Journal of Geriatric Psychiatry, in press.
| McNiel || Hung || Hall || Binder |
McNiel, D. E. , Hung, E. K., Cramer, R. J., Hall, S. E., & Binder, R. L. (2011) An approach to evaluating competence in assessing and managing violence risk. Psychiatric Services, 62(1), 90-92.
|Prochaska||Prochaska, J. J. (2010) Integrating tobacco treatment into mental health settings. Journal of the American Medical Association, 304, 2534-2535.|
|Rubenstein||A few recent John Rubenstein publications:|
Chao, H. T., Chen, H., Samaco, R. C., Xue, M., Chahrour, M., Yoo, J., Neul, J. L., Gong, S., Lu, H. C., Heintz, N., Ekker, M., Rubenstein, J. L., Noebels, J. L., Rosenmund, C., & Zoghbi, H. Y. (2010) Dysfunction in GABA signaling mediates autism-like stereotypes and Rett syndrome phenotypes. Nature, 468(7321), 263-269.
Lek, M., Dias, J. M., Marklund, U., Uhde, C. W., Kurdija, S., Lei, Q., Sussel, L., Rubenstein, J. L., Matise, M. P., Arnold, H. H., Jessell, T. M., & Ericson, J. (2010) A homeodomain feedback circuit underlies step-function interpretation of a Shh morphogen gradient during ventral neural patterning. Development, 137(23), 4051-4060.
McKenna, W. L., Betancourt, J., Larkin, K. A., Abrams, B., Guo, C., Rubenstein, J. L., & Chen, B. (2011) Tbr1 and Fezf2 regulate alternate corticofugal neuronal identities during neocortical development. Journal of Neuroscience, 31(2), 549-564.
Rubenstein, J. L. (2010) Development of the cerebral cortex: Implications for neurodevelopmental disorders. Journal of Child Psychology and Psychiatry, 2010 Aug 24. DOI: 10.1111/j.1469-7610.2010.02307.x. [Epub ahead of print] PMID: 20735793.
Sajan, S. A., Rubenstein, J. L., Warchol, M. E., & Lovett, M. (2011) Identification of direct downstream targets of Dlx5 during early inner ear development. Human Molecular Genetics (in press) PMID: 21227998.
Wang, Y., Li, G., Stanco, A., Long, J. E., Crawford, D., Potter, G. B., Pleasure, S. J., Behrens, T., & Rubenstein, J. L. (2011) CXCR4 and CXCR7 have distinct functions in regulating interneuron migration. Neuron, 69(1), 61-76.
|Sorensen||James Sorensen’s work was written up in the Clinical Trials Network Bulletin: “The December 2010 issue of NIDA NOTES features a discussion on a recent NIDA-funded study, headed by Dr. James Sorensen, Co-PI of the Western States Node, which showed that methadone patients fare as well as drug-free patients in a therapeutic community setting. Historically, these two treatment options – methadone maintenance and therapeutic communities – have rarely been combined: therapeutic communities typically require abstinence and can be concerned that the presence of those on methadone maintenance could have an effect on the abstinence of others. Dr. Sorensen and colleagues, however, were able to show that while these issues may be significant, they do not necessarily have an effect on participants’ success. For this study, a total of 231 opioid-dependent participants were recruited at the time of their admission to Walden House, a San Francisco therapeutic community that has been accommodating methadone patients for over two decades; approximately half were receiving methadone. Participants were tested at 6, 12, 18, and 24 months, with the results showing no statistically significant difference in outcomes between the two groups. Dr. Sorensen’s work has had an influence on the growing tendency to integrate different medical treatment approaches within therapeutic communities.”|
|Yaffe||Whitmer, R. A., Quesenberry Jr., C. P., Zhou, J., & Yaffe, K. (2011) Timing of hormone therapy and dementia: The critical window theory revisited. Annals of Neurology, 69(1), 163-169. |